Azoximer bromide

Azoximer bromide is a macromolecular compound with high-molecular weight and not proved immunomodulating activity. It is using in 
CIS countries for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative. Azoximer bromide is sold under the trade name Polyoxidonium.
Polyoxidonium is registered in US Patent-5503830 from 1996, in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.